Compound ID | 2771
Class: Natural product antibiotic
| Details of activity: | Active against Mycobacterium tuberculosis; interferes with glucose utilization; competes as a substrate in adenosine anabolism |
| Description: | Natural product from Streptomyces tubercidicus; also shows anti-tumour activity; shows host toxicity in preclinical studies |
| Institute where first reported: | Scientific Research Institute, Tokyo |
| Year first mentioned: | 1957 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|